#Experimental COVID-19 drug reduced deaths in severe cases by 55%, maker claims
“Experimental COVID-19 drug reduced deaths in severe cases by 55%, maker claims” An experimental COVID-19 drug cut the risk of death among severely ill patients by more than half in a late-stage trial – an optimistic development that drove its manufacturer’s stock to fresh highs in trading this week. The drug, sabizabulin, was so effective…